FDA Inspection
Geneva Laboratories, IncGeneva Laboratories, Inc – FDA Inspection, Nov 4, 2025
Record Details
This FDA Inspection record concerns Geneva Laboratories, Inc, with an inspection on November 4, 2025, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · b95f90f3-14b6-420d-98a1-1e142083dfb3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1290960
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.63Equipment Design, Size and Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Geneva Laboratories, Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 3, 2021 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| April 5, 2018 | VAI | Minneapolis District Office | Project Evaluation: Devices |
| June 11, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 30, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 6, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Geneva Laboratories, Inc
- FDA Inspection 1143396 - 2021-06-03
- FDA Inspection 1046966 - 2018-04-05
- FDA Inspection 930535 - 2015-06-11
- FDA Inspection 761091 - 2011-12-30
- FDA Inspection 664201 - 2010-05-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.